RE:Bacteriophages are not proprietary
Cytophage employs cocktails of genetically modified bacteriophages (example: 5 to 12 different phages). The modify the binding domains of their custom-designed "Frankenstein-phages" to precisely target specific bacteria.
They have patent applications pending in the US, Canada, Europe, and Asia, all of which are publicly accessible for review—an impressive testament to their innovation pipeline.
Regarding human use, Cytophage has already achieved this critical milestone. Overcoming such a significant hurdle early on is a noteworthy achievement. Well done!
As a side note, phages are classified as "Generally Recognized as Safe" (GRAS) in the USA, and engineered phages are already being used commercially in various industries. In healthcare, companies like Adaptive Phage Therapeutics and Phico Therapeutics are exploring phage-based solutions for antibiotic-resistant infections. In the food industry, Intralytix and Micreos Food Safety lead the way with products targeting bacteria like Listeria and Salmonella. Additionally, in agriculture, companies like BiomX are developing phage therapies to protect crops from harmful bacteria.
It’s exciting to see Cytophage contributing to this growing field. Good luck to all!